Syntara (ASX:SNT) - Webinar Presentation

Company Presentations

by Finance News Network

Gary Phillips - CEO - Syntara (ASX:SNT) is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. The company has ongoing trials in myelofibrosis, myelodysplastic syndrome, scar prevention, modifcation of existing scars, isolated REM sleep behaviours disorder and Parkinson's Disease.

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?